Progenics Pharmaceuticals competitorsClear all

Progenics Pharmaceuticals's top competitors include Acerta Pharma, Ablynx and Exelixis.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
Acerta Pharma
Acerta Pharma
Acerta Pharma is a biopharmaceutical company.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Exelixis
Exelixis
Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.
Founding Date
Founding Date
1986
Founding Date
2013
Founding Date
2001
Founding Date
1994
Type
Type
Subsidiary
Type
Subsidiary
Type
Subsidiary
Type
Public
Tags
Locations
Locations
New York, US HQ
Billerica, US
Locations
South San Francisco, US HQ
Oss, NL
Oss, NL
Locations
Gent, BE HQ
Gent, BE
Locations
Alameda, US HQ
Employees
Employees
10533% increase
Employees
197
Employees
3821% decrease
Employees
61727% increase
Twitter followers
Twitter followers
292
Twitter followers
N/A
Twitter followers
261
Twitter followers
5.7 k
Alexa Website Rank
Alexa Website Rank
428737
Alexa Website Rank
N/A
Alexa Website Rank
389080
Alexa Website Rank
197956
Employee Rating
Employee Rating
2.8
Employee Rating
3.5
Employee Rating
3.2
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
$35m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
€85.2m (FY, 2016)
Revenue (est.)
$853.8m (FY, 2018)
Cost of goods
Cost of goods
$3.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$26.3m (FY, 2018)
Gross profit
Gross profit
$31.8m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$827.5m (FY, 2018)
Net income
Net income
($68.6m) (FY, 2019)
Net income
N/A
Net income
(€1.1m) (FY, 2016)
Net income
$690.1m (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 60m
Total funding raised
$ 498.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Acerta Pharma
HQ
South San Francisco, US

Acerta Pharma is a biopharmaceutical company.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company
Exelixis
HQ
Alameda, US
Employees
617↑ 27% increase

Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.

View company